Hospitalization as an Opportunity to Optimize Glycemic Control in Oncology Patients
- 21 Downloads
Purpose of Review
Many patients experience hyperglycemia during cancer treatment, either as a new-onset condition or as an exacerbation of existing diabetes. This can impact treatment and outcomes, increasing the risk of complications and worsening health-related quality of life (HRQoL). These issues may be particularly significant when patients are hospitalized and/or acutely ill. The purpose of this review is to identify common barriers and strategies specific to the inpatient setting to improve glycemic control and minimize complications both while patients are hospitalized and after discharge.
Hyperglycemia in patients who are hospitalized during cancer treatment is common, but there is a lack of consensus on goals and approaches to glycemic management in this setting. Hyperglycemia related to oncology treatment can have unusual causes and challenges in management. Organizational guidelines can help standardize treatment and guide providers in managing hyperglycemia in oncology patients during hospitalization and upon discharge. Hospitalization is a critical period that provides an opportunity to reassess and modify management plans, coordinate follow-up care, and, crucially, educate and empower patients to successfully manage their blood glucose levels once they are discharged. Emerging technology such as patient portals can facilitate hyperglycemia management after discharge.
This review discusses evidences and strategies to utilize the period of hospitalization to develop and implement an individualized plan of care for patients with concurrent hyperglycemia and cancer.
KeywordsOncology Diabetes Hyperglycemia Steroid-induced hyperglycemia Diabetes education Discharge Cancer treatment
Compliance with Ethical Standards
Conflict of Interest
Amy Hiestand and Ritika Chitkara declare that they have no conflict of interest.
James Flory reports personal fees from Genentech.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.•• Hershey DS. Importance of glycemic control in cancer patients with diabetes: treatment through end of life. Asia Pac J Oncol Nurs. 2017;4(4):313–8. This article highlights not only the important role of but also some of the challenges to glycemic management throughout the cancer treatment continuum. Emphasizing the need for consensus regarding goals of treatment and the individualized needs of this special subset of the diabetes population.PubMedPubMedCentralCrossRefGoogle Scholar
- 4.Duan W, Shen X, Lei J, Xu Q, Yu Y, Li R, et al. Hyperglycemia, a neglected factor during cancer progression. Biomed Res Int. 2014.Google Scholar
- 5.Overbeek JA, van Herk-Sukel MP, Vissers PA, van der Heijden AA, Bronsveld HK, Herings RM, et al. Type 2 diabetes, but not insulin (analog) treatment, is associated with more advanced stages of breast cancer: a national linkage of cancer and pharmacy registries. Diabetes Care. 2019;42(3):434–42.PubMedCrossRefPubMedCentralGoogle Scholar
- 9.American Diabetes Association. 12. Older adults: standards of medical care in diabetes-2019. Diabetes Care 42(Suppl 1):S139-S47.Google Scholar
- 13.National Cancer Institute. April 27, Cancer statistics. 2018 Available from https://www.cancer.gov/about-cancer/understanding/statistics. Accessed 16 May 2019.
- 14.Royal Australian College of General Practitioners (RACGP). General practice management of type 2 diabetes: 2016–18. 2016. Available from https://static.diabetesaustralia.com.au/s/fileassets/diabetes-australia/5d3298b2-abf3-487e-9d5e-0558566fc242.pdf. Accessed May 1 2019.
- 18.•• Gallo M, Muscogiuri G, Felicetti F, Faggiano A, Trimarchi F, Arvat E, et al. Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes. Metabolism. 2018;78:141–54. Reviews the coexistence of diabetes and cancer and the complications that often arise as a consequence of the comorbidity. Addresses some of the challenges of oncologic management and end-of-life care in patients with diabetes.PubMedCrossRefGoogle Scholar
- 21.•• Suh S, Park MK. Glucocorticoid-induced diabetes mellitus: an important but overlooked problem. Endocrinol Metab. 2017;32(2):180–9. This article addresses the problem of hyperglycemia while receiving glucocorticoids. Treatment of steroid-induced hyperglycemia tends be overlooked but can cause complications and poorer outcomes for patients with diabetes, as well as those without diabetes. They identify some common challenges in addition to treatment strategies and screening guidelines. CrossRefGoogle Scholar
- 30.Kang Z, Huo JL, Zhai XJ. Effects of perioperative tight glycemic control on postoperative outcomes: a meta-analysis. Endocr Connect 2018;1(aop).Google Scholar
- 40.Sauer AC. Malnutrition in patients with cancer: an often overlooked and undertreated problem. Oncology Nurse 2013. Available www.theoncologynurse.com/ton-issue-archive/2013-issues/october-vol-6-no-9/16012-malnutrition-in-patients-with-cancer-an-often-overlooked-and-undertreated-problem. Accessed 15 June 2019.
- 46.Korytkowski MT, Salata RJ, Koerbel GL, Selzer F, Karslioglu E, Idriss AM, et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care. 2009;32(4):594–6.PubMedPubMedCentralCrossRefGoogle Scholar
- 59.Amuta-Jimenez AO, Lo C, Talwar D, Khan N, Barry AE. Food label literacy and use among US adults diagnosed with cancer: results from a national representative study. J Cancer Educ. 2018:1–0.Google Scholar
- 60.Sonbol MB, Jain T, Firwana B, Hilal T, Deleon T, Murad A, et al. Neutropenic diets to prevent cancer infections: updated systematic review and meta-analysis. BMJ Support Palliat Care 2019: bmjspcare-2018.Google Scholar
- 67.Buffart LM, Kalter J, Sweegers MG, Courneya KS, Newton RU, Aaronson NK, et al. Effects and moderators of exercise on quality of life and physical function in patients with cancer: an individual patient data meta-analysis of 34 RCTs. Cancer Treat Rev. 2017;52:91–104.PubMedCrossRefPubMedCentralGoogle Scholar